Literature DB >> 23246288

Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes.

Mohammed S Orloff1, Xin He, Charissa Peterson, Fusong Chen, Jin-Lian Chen, Jessica L Mester, Charis Eng.   

Abstract

Cowden syndrome (CS) is a difficult-to-recognize multiple hamartoma syndrome with high risks of breast, thyroid, and other cancers. Germline mutations in PTEN on 10q23 were found to cause 85% of CS when accrued from tertiary academic centers, but prospective accrual from the community over the last 12 years has revealed a 25% PTEN mutation frequency. PTEN is the phosphatase that has been implicated in a heritable cancer syndrome and subsequently in multiple sporadic cancers and developmental processes. PTEN antagonizes the AKT1/PI3K signaling pathway and has roles in cell cycle, migration, cell polarity, and apoptosis. We report that 8 of 91 (8.8%) unrelated CS individuals without germline PTEN mutations carried 10 germline PIK3CA mutations (7 missense, 1 nonsense, and 2 indels) and 2 (2.2%) AKT1 mutations. These mutations result in significantly increased P-Thr308-AKT and increased cellular PIP3. Our observations suggest that PIK3CA and AKT1 are CS susceptibility genes.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246288      PMCID: PMC3542473          DOI: 10.1016/j.ajhg.2012.10.021

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

1.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.

Authors:  M Whitman; D Kaplan; T Roberts; L Cantley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

Review 2.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.

Authors:  Jeffrey A Engelman; Ji Luo; Lewis C Cantley
Journal:  Nat Rev Genet       Date:  2006-08       Impact factor: 53.242

3.  Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation.

Authors:  A D Kohn; F Takeuchi; R A Roth
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

4.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.

Authors:  D Liaw; D J Marsh; J Li; P L Dahia; S I Wang; Z Zheng; S Bose; K M Call; H C Tsou; M Peacocke; C Eng; R Parsons
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

Review 5.  Synthesis and function of 3-phosphorylated inositol lipids.

Authors:  B Vanhaesebroeck; S J Leevers; K Ahmadi; J Timms; R Katso; P C Driscoll; R Woscholski; P J Parker; M D Waterfield
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

6.  A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands.

Authors:  Min-Han Tan; Jessica Mester; Charissa Peterson; Yiran Yang; Jin-Lian Chen; Lisa A Rybicki; Kresimira Milas; Holly Pederson; Berna Remzi; Mohammed S Orloff; Charis Eng
Journal:  Am J Hum Genet       Date:  2010-12-30       Impact factor: 11.025

7.  The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.

Authors:  F B Furnari; H J Huang; W K Cavenee
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

8.  Phosphatidylinositol 3-kinase-dependent activation of mammalian protein kinase B/Akt in Saccharomyces cerevisiae, an in vivo model for the functional study of Akt mutations.

Authors:  Isabel Rodríguez-Escudero; Amparo Andrés-Pons; Rafael Pulido; María Molina; Víctor J Cid
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

9.  Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA.

Authors:  Marjorie J Lindhurst; Victoria E R Parker; Felicity Payne; Julie C Sapp; Simon Rudge; Julie Harris; Alison M Witkowski; Qifeng Zhang; Matthijs P Groeneveld; Carol E Scott; Allan Daly; Susan M Huson; Laura L Tosi; Michael L Cunningham; Thomas N Darling; Joseph Geer; Zoran Gucev; V Reid Sutton; Christos Tziotzios; Adrian K Dixon; Timothy Helliwell; Stephen O'Rahilly; David B Savage; Michael J O Wakelam; Inês Barroso; Leslie G Biesecker; Robert K Semple
Journal:  Nat Genet       Date:  2012-06-24       Impact factor: 38.330

10.  Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.

Authors:  Li Du; Jingping Shen; Andrew Weems; Shi-Long Lu
Journal:  J Oncol       Date:  2012-05-16       Impact factor: 4.375

View more
  57 in total

1.  Germline PARP4 mutations in patients with primary thyroid and breast cancers.

Authors:  Yuji Ikeda; Kazuma Kiyotani; Poh Yin Yew; Taigo Kato; Kenji Tamura; Kai Lee Yap; Sarah M Nielsen; Jessica L Mester; Charis Eng; Yusuke Nakamura; Raymon H Grogan
Journal:  Endocr Relat Cancer       Date:  2015-12-23       Impact factor: 5.678

Review 2.  Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models.

Authors:  Verónica Martínez-Cerdeño
Journal:  Dev Neurobiol       Date:  2016-08-30       Impact factor: 3.964

3.  A pathogenic role for germline PTEN variants which accumulate into the nucleus.

Authors:  Janire Mingo; Isabel Rodríguez-Escudero; Sandra Luna; Teresa Fernández-Acero; Laura Amo; Amy R Jonasson; Roberto T Zori; José I López; María Molina; Víctor J Cid; Rafael Pulido
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

4.  Insertion of Alu elements at a PTEN hotspot in Cowden syndrome.

Authors:  Louise Crivelli; Virginie Bubien; Natalie Jones; Jennifer Chiron; Françoise Bonnet; Emmanuelle Barouk-Simonet; Patrice Couzigou; Nicolas Sevenet; Frédéric Caux; Michel Longy
Journal:  Eur J Hum Genet       Date:  2017-05-17       Impact factor: 4.246

5.  Many mosaic mutations.

Authors:  W D Foulkes; F X Real
Journal:  Curr Oncol       Date:  2013-04       Impact factor: 3.677

Review 6.  Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway.

Authors:  Neera Nathan; Kim M Keppler-Noreuil; Leslie G Biesecker; Joel Moss; Thomas N Darling
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 7.  The duality of human oncoproteins: drivers of cancer and congenital disorders.

Authors:  Pau Castel; Katherine A Rauen; Frank McCormick
Journal:  Nat Rev Cancer       Date:  2020-04-27       Impact factor: 60.716

Review 8.  New genes emerging for colorectal cancer predisposition.

Authors:  Clara Esteban-Jurado; Pilar Garre; Maria Vila; Juan José Lozano; Anna Pristoupilova; Sergi Beltrán; Anna Abulí; Jenifer Muñoz; Francesc Balaguer; Teresa Ocaña; Antoni Castells; Josep M Piqué; Angel Carracedo; Clara Ruiz-Ponte; Xavier Bessa; Montserrat Andreu; Luis Bujanda; Trinidad Caldés; Sergi Castellví-Bel
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

9.  Identification and Characterization of a Novel Constitutional PIK3CA Mutation in a Child Lacking the Typical Segmental Overgrowth of "PIK3CA-Related Overgrowth Spectrum".

Authors:  Nataliya Di Donato; Andreas Rump; Ghayda M Mirzaa; Diana Alcantara; Antony Oliver; Evelin Schrock; William B Dobyns; Mark O'Driscoll
Journal:  Hum Mutat       Date:  2015-12-15       Impact factor: 4.878

10.  Whole-genome copy number variation analysis in anophthalmia and microphthalmia.

Authors:  K F Schilter; L M Reis; A Schneider; T M Bardakjian; O Abdul-Rahman; B A Kozel; H H Zimmerman; U Broeckel; E V Semina
Journal:  Clin Genet       Date:  2013-06-17       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.